0001209191-20-030479.txt : 20200519 0001209191-20-030479.hdr.sgml : 20200519 20200519162823 ACCESSION NUMBER: 0001209191-20-030479 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20894000 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Adm, Leg & BD Off Common Stock 2020-05-15 4 S 0 1 273.91 D 26905 D Common Stock 2020-05-15 4 S 0 2 275.54 D 26903 D Common Stock 2020-05-15 4 S 0 2 276.46 D 26901 D Common Stock 2020-05-15 4 S 0 1 278.69 D 26900 D Common Stock 2020-05-15 4 S 0 11 280.34 D 26889 D Common Stock 2020-05-15 4 S 0 4 282.02 D 26885 D Common Stock 2020-05-15 4 S 0 4 283.03 D 26881 D Common Stock 2020-05-15 4 S 0 3 284.03 D 26878 D Common Stock 2020-05-15 4 S 0 4 285.19 D 26874 D Common Stock 2020-05-15 4 S 0 9 286.27 D 26865 D Common Stock 2020-05-15 4 S 0 18 287.50 D 26847 D Common Stock 2020-05-15 4 S 0 9 288.23 D 26838 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $275.54 (range $275.25 to $275.83). Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $276.46 (range $276.44 to $276.49). Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.74 to $280.73). Open market sales reported on this line occurred at a weighted average price of $282.02 (range $281.42 to $282.38). Open market sales reported on this line occurred at a weighted average price of $283.03 (range $282.45 to $283.31). Open market sales reported on this line occurred at a weighted average price of $284.03 (range $283.56 to $284.37). Open market sales reported on this line occurred at a weighted average price of $285.19 (range $284.70 to $285.63). Open market sales reported on this line occurred at a weighted average price of $286.27 (range $285.70 to $286.68). Open market sales reported on this line occurred at a weighted average price of $287.50 (range $286.96 to $287.88). Open market sales reported on this line occurred at a weighted average price of $288.23 (range $287.96 to $288.47). /s/ Sabrina Yohai, Attorney-in-Fact 2020-05-19